ERC Starting Grant · 2022
The extremely popular engineering field of drug-eluting biodegradable scaffolds for regenerative medicine, cancer treatment and cardiovascular therapies has largely failed to ensure therapy at the right place, at the right time and with the right dose. Control of actuated drug release is the grand challenge to solve. Previous attempts struggled because, at this time, no technology is able to cope with the influence of scaffold alterations with degradation. MAD Control will establish a multifunctional platform for biodegradable cardiovascular scaffolds and (i) make model-based predictions of degradation states from real-time imaging, (ii) reveal which actuation is best for targeted drug…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.
← All labs at Helmut Schmidt University - University of the Bundeswehr Hamburg